| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $126.3M | +1672.2% |
| R&D Expense | $145.9M | -15.6% |
| SG&A Expense | $87.7M | +10.1% |
| Operating Income | -$108.0M | +56.2% |
| Interest Expense | $13.2M | +118.9% |
| Income Tax | $0 | — |
| Net Income | -$113.7M | +54.5% |
| EPS (Basic) | -$0.89 | +61.5% |
| EPS (Diluted) | -$0.89 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.0M | -21.5% |
| Short-term Investments | $0 | -100.0% |
| Inventory | $29.6M | — |
| Current Assets | $175.4M | -9.9% |
| Total Assets | $358.6M | +2.8% |
| Current Liabilities | $98.7M | +15.3% |
| Long-term Debt | $110.0M | +120.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$117.4M | +48.7% |
| Capital Expenditures | $8.0M | -18.8% |
| Investing Cash Flow | $10.6M | -87.2% |
| Financing Cash Flow | $71.7M | -44.7% |
| Free Cash Flow | -$125.3M | +47.5% |
| +61.5% |
| Total Liabilities |
| $403.5M |
| +19.4% |
| Stockholders' Equity | -$44.9M | -516.0% |